Kisspeptin and GPR54 immunoreactivity in a cohort of 518 patients defines favourable prognosis and clear cell subtype in ovarian carcinoma
518 名患者队列中的 Kisspeptin 和 GPR54 免疫反应性决定了卵巢癌的良好预后和透明细胞亚型
期刊:BMC Medicine
影响因子:7
doi:10.1186/1741-7015-5-33
Leah M Prentice, Christian Klausen, Steve Kalloger, Martin Köbel, Steven McKinney, Jennifer L Santos, Challayne Kenney, Erika Mehl, C Blake Gilks, Peter Leung, Ken Swenerton, David G Huntsman, Samuel A J Aparicio
